Both in Pharmaceuticals
Pfizer vs Teva Pharmaceutical Industries Limited
Over the past year PFE returned +23.8% and TEVA returned +105.1%; their daily moves had a correlation of 0.22.
PFE +23.8% TEVA +105.1%Growth of $1, one year, split-adjusted
| Metric | PFE | TEVA |
|---|---|---|
| Price | $30.52 | $42.09 |
| Market cap | $173.95B | $49.09B |
| Today | +1.90% | +1.50% |
| 1 month | +8.5% | +7.1% |
| 6 months | +15.9% | +20.4% |
| Year to date | +22.6% | +34.9% |
| 1 year | +25.6% | +108.1% |
| Revenue growth (YoY) | +2.6% | −0.8% |
| Gross margin | 72.8% | 52.0% |
| Net margin | −1.6% | −13.9% |
| P/E (TTM) | 40.2× | 69.4× |
| Price / sales | 2.7× | 2.8× |
| Net cash | -$51.49B | -$12.94B |
| Dividend yield | 5.64% | — |
| Volatility (60d) | 19.8% | 27.4% |
| Short % of float | 2.4% | 2.4% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).